X4 Pharmaceuticals - XFOR Company Short-Term Debt

Graphic logo of X4 Pharmaceuticals (XFOR)

Geopolitical tensions and sanctions are complicating component logistics and global trials for X4 Pharmaceuticals (XFOR). The company is mitigating risks by diversifying its oral blood treatment agents. Sales of an approved immune drug provide a steady cash generator. On the GURU.Markets platform, current short-term debt levels demonstrate financial discipline, where the 0.00 level records fresh values.

XFOR (X4 Pharmaceuticals Inc.) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

X4 Pharmaceuticals, Inc - analytical breakdowns and key metrics (XFOR)

- price and consensus price forecast:
Price Chart X4 Pharmaceuticals, Inc.|XFOR - Fair Value Consensus
- market capitalization data:
Market Value X4 Pharmaceuticals, Inc.|XFOR - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share X4 Pharmaceuticals|XFOR - Book Capitalization|Market Cap to Net Assets Ratio x4pharma.com|XFOR - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital X4 Pharmaceuticals|XFOR - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity X4 Pharmaceuticals|XFOR - Company Total Debt|Debt to Book Capitalization Ratio X4 Pharmaceuticals, Inc.|XFOR - Company Long-Term Liabilities|Company Current Liabilities X4 Pharmaceuticals
Fundamental company valuation:X4 Pharmaceuticals, Inc. - XFOR
Product sample of X4 Pharmaceuticals

Liquidity during the product launch and distribution development phase is a critical stability factor for X4 Pharmaceuticals (XFOR). By analyzing the short-term debt balance, an investor can evaluate liabilities maturing within one year against US industry benchmarks. The trend of this indicator reflects the biotech's ability to service current loans without external financing, which directly impacts the calculation of the business's fair value.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|NKTR - Short-Term Debt|Upstream Bio Corp (UPB) - Company Current Liabilities|ZBIO (Zenas Corp) - Company Short-Term Indebtedness|IMNM (Immunome, Inc.) - Company Short-Term Indebtedness|gossamerbio.com - Company Current Liabilities|Company Short-Term Loans and Borrowings KalVista Pharmaceuticals, Inc.|Septerna, Inc. - Company Short-Term Debt|Current Liabilities PVLA|SVRA (Savara Pharma) - Company Short-Term Debts|Company Short-Term Loans and Borrowings RIGL (Rigel Pharmaceuticals)|Company Short-Term Debts anaptysbio.com ANAB|ATXS - Company Short-Term Debts|Company Short-Term Debt ENGN (enGene Holdings Inc)|RAPT Therapeutics (RAPT) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Aerovate Therapeutics|ACRS (Aclaris Therapeutics) - Company Current Liabilities|Company Short-Term Debts kyvernatx.com|Company Short-Term Debts TLSA|Company Short-Term Debts Cabaletta Bio Inc. CABA|Company Current Liabilities VTYX (Ventyx Bio)|Theratechnologies, Inc (THTX) - Company Short-Term Debts|AVTX: Short-Term Debt|ELDN - Company Current Liabilities|AGEN (Agenus Inc.) - Company Short-Term Debts|CLYM: Company Current Liabilities|ZURA (Zura Bio) - Amount of Current Liabilities|aTyr Pharmaceuticals (ATYR) - Company Short-Term Debts|Short-Term Debt Volume ADAG|Company Short-Term Debts ikenaoncology.com IMA|Company Current Liabilities STTK (Shattuck Labs)|Company Short-Term Debts Equillium Inc EQ|CNTB - Company Short-Term Debts|IMUX: Company Short-Term Debt|atarabio.com (ATRA) - Company Short-Term Debt|IFRX - Company Short-Term Debt|Short-Term Debt Volume ACET|Company Current Liabilities CELU (Celularity Corp)|Company Short-Term Indebtedness INMB|BRNS: Company Short-Term Debts|Current Liabilities Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - Company Short-Term Debt|AKTX - Short-Term Debt|Company Short-Term Debt ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Company Short-Term Loans and Borrowings|Company Short-Term Debt GOVX (GeoVax Corp)|EDSA (Edesa Biotech, Inc.) - Current Liabilities|IBIO: Company Short-Term Debts|Company Short-Term Loans and Borrowings CARM|Company Short-Term Debts XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts Bolt Biotherapeutics, Inc. BOLT|Company Short-Term Debt HCWB|APVO - Company Short-Term Loans and Borrowings|aimimmuno.com (AIM) - Company Short-Term Debt|ADTX: Company Current Liabilities|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debts XRTX|HIND: Company Current Liabilities|Company Short-Term Loans and Borrowings REVB|Company Short-Term Debts indaptusrx.com|Short-Term Debt Volume Scinai Immunotherapeutics Ltd. SCNI|CALI - Company Short-Term Debt|AFMD - Company Current Liabilities|Allakos Inc. (ALLK) - Company Short-Term Debt|HOOK (hookipapharma.com) - Company Current Liabilities|IGM Biosciences (IGMS) - Company Current Liabilities|Company Short-Term Debts iTeos Therapeutics, Inc.|Company Short-Term Debt OCEA (Ocean Biomedical Inc)|Company Short-Term Indebtedness TCBP|THRD - Company Short-Term Debts